Facebook
Twitter
LinkedIn

Timothy Herpin

Timothy Herpin Ph.D., is CBO of Caribou Biosciences where he leads the company’s efforts in the areas of strategic partnerships, licensing agreements, and other value creation opportunities. Prior to Caribou, Tim was Vice President, Head of Transactions at AstraZeneca and led a group of business development professionals involved in all aspects of transactions negotiation and execution. Tim joined AstraZeneca in 2011 as Vice-President, Strategic Partnering and Business Development, initially for Neuroscience and subsequently for Oncology. Prior to AstraZeneca, Tim spent eight years in the business development organization at Bristol-Myers Squibb covering both search and evaluation as well as transaction in multiple disease areas. Before his business development career, Tim worked in R&D at Bristol-Myers Squibb, Aventis and Pharmacopeia. Tim grew up in Paris and is a graduate of Ecole Polytechnique in France. He also holds a Ph.D. in organic chemistry from University College London and an MBA in Finance from NYU Stern.